NCT07872072|Not Yet RecruitingFDA Device
HomeCare Medication Management for People With Dementia
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
Loading search results
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
Sponsor study identifier
NIH
Secondary identifiers
NIH
interventional
120
1 country
1
Study Start
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
May 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
May 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This study will evaluate whether the HomeCare medication management system can improve medication adherence and related outcomes for adults age 65 and older living with dementia, Alzheimer's disease, or related dementias. HomeCare is an internet-connected medication management device that can automate medication dispensing, monitor medication use, and provide alerts to caregivers. The system is integrated with a Pharmacy Distribution System designed to track medications from pharmacy delivery through use in the home. A total of 120 participants with dementia will be randomly assigned to one of two groups. One group will use the HomeCare system, while the other group will continue using standard medication management methods, such as pill bottles or blister packs. Participants will be followed for 12 months. The main outcome is medication adherence. The study will also examine hospitalizations and emergency room visits, cognitive function, caregiver burden, quality of life, satisfaction, and changes in medication-management behavior. Caregivers will also participate in surveys and study assessments. The study is intended to determine whether HomeCare can improve medication management and support both people living with dementia and their caregivers.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 7, 2026
Actual (reported)October 13, 2026
Actual (reported)January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
May 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
May 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Medication Adherence
Medication adherence will be assessed using the Medication Adherence Rating Scale (MARS) and Proportion of Days Covered (PDC). The HomeCare system will track adherence through its automated logging of medication usage and AI-powered monitoring algorithms.
12 months
Incidence of Hospitalizations
12 months
ECOG Cognitive Assessment
Baseline, 6 months, 12 months
Participants in this arm will use the HomeCare system for medication management. The HomeCare system automates medication reminders, records medication intake, and provides caregivers with real-time alerts about adherence and patient behaviors. The system integrates medication dispensing, adherence monitoring, Video Directly Observed Therapy (VDOT), intervention support, and prescription information over the 12-month study period.
Participants in this arm will follow the current standard of care for medication management using manual methods such as pill bottles or blister packs. Caregivers or participants will manually track medication adherence and manage medication schedules without technological assistance.
An automated, secure, AI driven medication delivery and observation platform to maximize therapy compliance, provide continuous medication monitoring and outcomes for individuals impacted by AD/ADRD.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University of California, Davis
Davis, California, 95618-6153, United States
First Submitted
October 7, 2026
First Posted
October 13, 2026
Study Start
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
May 31, 2027
EstimatedThe Impact of Music Intervention on Sleep
Zarit Burden Interview (ZBI) Score
Baseline, 6 months, 12 months
Behavioral Changes in Medication Management
12 months
EQ-5D-5L Health Questionnaire
Baseline, 6 months, 12 months
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
May 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 13, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: